Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019) – Daedal ResearchThe report titled “Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market.
By: Daedal Research The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country. The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments. Country Coverage United States India Australia Company Coverage Monash Group OvaScience Vitrolife Executive Summary IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant. Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies. The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market. List of Figures: Figure 1: IVF Treatment Procedure Figure 2: Causes of Infertility; Figure 3: Global Rate of Natural Conception by Age Group over a Year (%); 2014 Figure 4: Global IVF Market by Value; 2012-2014 (US$ Billion) Figure 5: Global IVF Market by Value; 2015E-2019E (US$ Billion) Figure 6: Global IVF Market Share by IVF Cycles per Regions; 2013 Figure 7: Global IVF Treatment Costs by Regions; 2014 (US$) Figure 8: Global Fertility Rates by Regions; 2014 Figure 9: Global IVF Penetration (woman undertaking IVF as % of total births); 2013 Figure 10: Global IVF Market by Segments; 2013 Figure 11: Global IVF Market by Key Players; 2013 Figure 13: Australia Number of IVF Cycles per Women; 2009-2014 Figure 12: Australia Number of Fresh IVF Cycles per Women by Age Group; 2013 Figure 14: Australia IVF Market Size by Value; 2010-2014 (US$ Million) Figure 15: Australia IVF Market Size by Value; 2015E-2019E (US$ Million) Figure 16: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2008-2013 Figure 17: Australia & New Zealand IVF Market Size by Number of IVF Cycles; 2014E-2019E Figure 18: Australia Female Population by Age Group; 2003-2013 (Millions) Figure 19: IVF Penetration in Australia; 2002-2013 Figure 20: Australia Fertility Rates; 2005-2013 (births per women) Figure 21: India IVF Market by Value; 2012-2014 (US$ Million) Figure 22: India IVF Market by Value; 2015E-2019E (US$ Million) Figure 23: India IVF Market by No. of IVF Cycles; 2014-2019E (in 000s) Figure 24: India Fertility Rates; 2010-2014 (births per women) Figure 25: The US Fertility Treatment Costs; 2014 (US$) Figure 26: Cumulative Success Rate of IVF Procedure in the US; 2014 Figure 27: The US IVF Market by Value; 2010-2014 (US$ Billion) Figure 28: The US IVF Market by Value; 2015E-2019E (US$ Billion) Figure 29: The US IVF Market Size by Number of IVF Procedures; 2002-2014 (in 000s) Figure 30: The US IVF Market Size by Number of IVF Procedures; 2014E-2019E (in 000s) Figure 31: The US IVF Market Size by Number of Infants Births by Using IVF; 2002-2014 (in 000s) Figure 32: The US IVF Market Size by Number of Infants Births by Using IVF; 2015E-2019E (in 000s) Figure 33: Number of IVF Cycles in the US by Age Group; 2013 Figure 34: Average No. of Embryos Transferred in the US; 2013 Figure 35: Percentage of Transfers Resulting in Live Births in the US; 2013 For further details, kindly visit : http://www.daedal- Rajeev Kumar (Business Development Manager) Address: 36 SFS Flats Paschim Vihar New Delhi-110063 Mobile: +91-8743975789 Tel: +91-120-4553017 Mail ID - info@daedal- Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. For more Information: http://www.daedal- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|